Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer

Frontiers in Immunology

Immunology

Aihua Li¹  Xianzheng Zhang²  Xiaolin Li³  Peng Xie⁴ 

[1] Department of Obstetrics and Gynaecology, Liaocheng People’s Hospital, Liaocheng, Shandong, China;Department of Oncology, Liaocheng People’s Hospital, Liaocheng, Shandong, China;Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China;Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China;Shandong University, Jinan, Shandong, China;

关键词: cervical cancer;    immune microenvironment;    immunotherapy;    PD-1;    TCGA;   

DOI  :  10.3389/fimmu.2023.1281775

 received in 2023-08-23, accepted in 2023-08-31,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Li, Zhang, Li and Xie